-
In August, for example, Redux, a weight-loss pill, was withdrawn from sale for fear that it causes heart problems.
ECONOMIST: Biotechnology
-
Shrugging off the past, Arena Pharmaceuticals Chief Executive Jack Lief thinks he has a new weight-loss pill that will work.
FORBES: Magazine Article
-
But drugmakers, try as they may, have so far failed to produce a blockbuster weight-loss pill that's safe and reliable.
FORBES: Magazine Article
-
U.S. approval of Sanoifi's weight-loss pill rimonabant, which some analysts and doctors said could be one of the biggest drugs ever, has been delayed for seven months and counting.
FORBES: Magazine Article
-
U.S. approval of Sanoifi's (nyse: SNY - news - people ) weight-loss pill rimonabant, which some analysts and doctors said could be one of the biggest drugs ever, has been delayed for seven months and counting.
FORBES: Sanofi Remains Tight-Lipped
-
Pfizer 's (nyse: PFE - news - people ) arthritis pill Bextra, Abbott Laboratories ' (nyse: ABT - news - people ) weight loss pill, Meridia, GlaxoSmithKline 's (nyse: GSK - news - people ) asthma drug, Serevent and Roche 's acne pill, Accutane all made the list.
FORBES: Grading Merck's Defense
-
Obesity drug developer Vivus posted results from a 2-year study of its combination weight loss pill Qnexa this morning, showing maintenance of an 11.4% and 10.4% weight loss for patients taking two doses of the medicine, compared to 2.5% for patients on placebo.
FORBES: Vivus Still Facing Rejection -- For Now